Curebound’s annual Concert for Cures has reached a major milestone, raising an astonishing $8.25 million in a single night. The 2026 benefit concert, headlined by global music icon P!NK, brings the total raised across the four-year history of the event series to more than $28 million. Funds from the concert directly support vital adult and pediatric cancer research.
The high-energy event took place at San Diego's Petco Park, drawing a massive crowd of 25,000 fans. Among the attendees were thousands of cancer survivors, including 1,500 individuals who were invited to attend the special evening by the Manchester Family Foundation.
P!NK delivered an exhilarating, high-flying performance that kept the stadium crowd on its feet from the very first note. Known worldwide for her fearless live shows and powerhouse vocals, the global superstar performed her biggest hits alongside emotional, stripped-down moments. During her performance, she praised the organization's efforts from the stage, expressing her deep gratitude for being able to support such an important cause.
Since launching in 2022, the Concert for Cures has united over 60,000 people. P!NK joins an illustrious roster of past A-list headliners that includes Elton John, Ed Sheeran, and Alicia Keys. The benefit has grown exponentially each year, emerging as a marquee night where entertainment, science, and community intersect to accelerate the fight against cancer.
Curebound CEO Robin Toft emphasized the urgency of the mission during the event, noting that the community's support matters more than ever at a time when national research funding remains uncertain. Board Chair Rick Valencia added that the organization ultimately measures its success by the breakthroughs that give families more options, more time, and more hope.
The event also received strong backing from sponsors, including luxury watch and jewelry maker Chopard. Through these combined efforts, the memorable night successfully generated crucial funding to define how the next generation prevents, detects, and treats cancer.
